A Study to Assess Myocardial Blood Flow Changes in Oncology Patients


About this study

The primary purpose of this study is to determine if ICI administration causes microvascular damage/endothelial function.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals 18 years or older.
  • Individuals able and willing to give consent to under PET/CT.

Exclusion Criteria:

  • Age < 18 years old.
  • Women who are pregnant, or breast-feeding.
  • Unable or unwilling to give consent to undergo PET/CT.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

John Bois, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer